By Anya George Tharakan
(Reuters) - U.S. stocks were little changed on Friday as a slide in Amgen dragged down the healthcare sector, offsetting gains in technology shares.
The S&P 500 healthcare sector was off 0.4 percent, dragged down by a 6.3 percent drop in Amgen. Analysts said data from a large study testing the impact of Amgen's cholesterol drug on the heart was weaker than expected.
Amgen was also the biggest drag on the broader S&P 500 index and the Nasdaq.
However, ten of the 11 major S&P 500 sectors were higher, with the technology sector up 0.21 percent.
Adobe gave the biggest push to the sector, rising 6.2 percent after the Photoshop maker's quarterly results beat analysts' expectations.
At 9:41 a.m. ET (1341 GMT), the Dow Jones Industrial Average was up 13.29 points, or 0.06 percent, at 20,947.84, the S&P 500 was up 1.25 points, or 0.05 percent, at 2,382.63 and the Nasdaq Composite was down 1.58 points, or 0.03 percent, at 5,899.18.
"Today it appears as though we're going to have another day like yesterday, where the market is looking for something substantial to create the next move," said Andre Bakhos, managing director at Janlyn Capital in Bernardsville, New Jersey.
Much of the week's trading has been predicated on a widely expected quarter-point interest rate hike that the Federal Reserve delivered on Wednesday.
The main indexes are on track to mark slight gains since Monday as markets rallied on the Fed's less hawkish-than-expected rate hike outlook.
Investors are also keeping a close eye on the Group of 20 meeting in Germany, where financial leaders and central banks discuss the world economy.
Tiffany's shares rose 3 percent to $92.73, after the company posted a better-than-expected fourth-quarter profit, boosted by strong demand for its high-end jewelry in Japan and China.
Advancing issues outnumbered decliners on the NYSE by 1,535 to 1,050. On the Nasdaq, 1,353 issues fell and 989 advanced.
The S&P 500 index showed 39 new 52-week highs and one new low, while the Nasdaq recorded 64 new highs and 31 new lows.
(Reporting by Anya George Tharakan and Yashaswini Swamynathan in Bengaluru; Editing by Anil D'Silva)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
